Booker Urges Supreme Court to Let State Roundup Cancer Suits Proceed
Sen. Cory Booker has filed an amicus brief with the U.S. Supreme Court in Monsanto Company v. John L. Durnell, backing a cancer patient who alleges Monsanto failed to warn about non‑Hodgkin lymphoma risks from long‑term exposure to Roundup’s active ingredient, glyphosate. The case turns on whether federal pesticide‑labeling law under FIFRA preempts state‑law failure‑to‑warn claims, a ruling that could effectively shut down or preserve thousands of Roundup lawsuits in state courts. Booker argues that Monsanto is asking the Court for a sweeping federal shield from liability that it has been unable to win from Congress, and says FIFRA sets minimum national standards but was never meant to bar state‑level suits that surface new safety concerns as science evolves. The Trump administration’s Justice Department has sided with Monsanto, telling the Court federal regulators’ approval of Roundup’s label should override state claims, while the company stresses the need for a uniform national labeling framework and cites hundreds of studies it says show glyphosate is safe. The brief comes as Bayer, Monsanto’s parent, has already paid more than $10 billion to resolve Roundup cases and is pursuing a proposed $7.25 billion settlement, and as scientific and regulatory bodies remain split, with the WHO calling glyphosate a probable carcinogen and the EPA saying it is unlikely to cause cancer when used as directed.
📌 Key Facts
- Booker filed an amicus brief Wednesday supporting plaintiff John L. Durnell in Monsanto Company v. Durnell at the U.S. Supreme Court.
- The case asks whether FIFRA preempts state‑law failure‑to‑warn claims over Roundup, potentially determining the fate of thousands of cancer suits.
- Bayer has already paid more than $10 billion to resolve Roundup‑related claims and is pursuing an additional proposed $7.25 billion settlement.
- The Trump Justice Department filed a separate brief backing Monsanto, arguing federal pesticide labeling rules should preempt state warning claims.
- Glyphosate is deemed a probable carcinogen by the WHO, while the EPA maintains it is not likely to cause cancer when used as directed.
📊 Relevant Data
Age-adjusted incidence rates for non-Hodgkin lymphoma in the US (2017-2021) are 19.6 per 100,000 for Whites, 18.7 for Hispanics, 15.6 for Blacks, 13.5 for Asians/Pacific Islanders, and 15.5 for American Indians/Alaska Natives, compared to the overall rate of 18.6 per 100,000.
Non-Hodgkin Lymphoma — Cancer Stat Facts — SEER (Surveillance, Epidemiology, and End Results Program)
US crop farmworkers are disproportionately Hispanic, with 69% identifying as Hispanic in 2015-2016 surveys, compared to Hispanics making up about 18% of the US population; farmworkers have higher exposure to pesticides like glyphosate due to occupational factors.
Findings from the National Agricultural Workers Survey (NAWS) 2015-2016 — US Department of Labor
Meta-analyses indicate that occupational exposure to pesticides, including glyphosate, is associated with a 41% increased risk of non-Hodgkin lymphoma, based on studies from 2014-2020.
Glyphosate Use and Cancer Incidence in the Agricultural Health Study — Journal of the National Cancer Institute
📰 Source Timeline (1)
Follow how coverage of this story developed over time